With over 10 years of experience in product marketing, and 8 years of digital content and technical writing experience, I am a smart, passionate, and versatile marketing professional who can help tech companies in the healthcare and pharma space grow their brand awareness, generate leads, and launch new products. My core competencies include GTM strategy, branding, messaging, content marketing, product marketing, lead generation, event management and marketing operations. I am currently a marketing consultant, providing fractional CMO/director services to clients who need strategic and tactical support, primarily via healthlaunchpad, the leading ABM agency for health tech. I have experience in developing content marketing strategy and execution, creating engaging and informative content for various channels, such as blogs, whitepapers, case studies, webinars, and social media. I have collaborated with C-suite and sales and product executives to develop and deliver product marketing materials, such as launch plans, value propositions, positioning statements, and sales enablement tools. I have leveraged HubSpot expertise to build out CRM systems to optimize marketing automation and sales operations, and measure and report on marketing performance and ROI as well as sales activity. Being skillful at maintaining a higher profit margin via monitoring KPIs such as MQL to SQL to opportunity conversion rates, CAQ, CLTV, ARR and MRR, I have optimized market opportunities while increasing market share in collaboration with growth teams. I hold a proven record of conducting market analysis to understand the competitive landscape and help establish product differentiators. I am motivated by the mission of improving health outcomes and advancing medical research through technology, and I bring diverse perspectives and experiences to the team as a magna cum laude graduate in Journalism and English, post-bacc pre-med student, and former senior product marketing director at par8o, a health tech company acquired by CloudMed (now R1) in 2021.